The present invention relates, generally, to inositol 1,4,5-triphosphate receptors (IP3R), and, in particular, to methods of modulating the activity of 220 kDa ankyrin-B in cellular localization and physiological function of IP3R. The invention further relates to methods of identifying compounds suitable for use in such methods and to compounds so identified.

 
Web www.patentalert.com

> Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof

~ 00306